Surgery Partners, Inc. (NASDAQ: SGRY) had its price target lowered by analysts at Citigroup Inc. from $42.00 to $38.00. They now have a "buy" rating on the stock.
Surgery Partners, Inc. Announces First Quarter 2024 Results [Yahoo! Finance]
Surgery Partners, Inc. Announces First Quarter 2024 Results
Surgery Partners, Inc. (NASDAQ: SGRY) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
Should You Invest in Surgery Partners (SGRY)? [Yahoo! Finance]